Treatment that is given to help a primary (original) treatment keep working. Maintenance therapy is often given to help keep cancer in remission.The average duration of maintenance therapy for ALL ranges between 2 and 3 years. Treatment given for a period of months or years to maintain remission and further decrease residual leukema or lymphoma cells in the body. In acute lymphoblastic leukemia , for example, treatment is maintained for several years after remission is induced.
Treatment consisted of standard four-drug induction therapy followed by a risk-based intensification phase, reinduction therapy, late intensification, and remission maintenance therapy (total of 104 weeks).